Robeco Institutional Asset Management B.V. Buys 42,774 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Robeco Institutional Asset Management B.V. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 13.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 356,144 shares of the medical equipment provider's stock after acquiring an additional 42,774 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.10% of Intuitive Surgical worth $176,387,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Atala Financial Inc acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $25,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. Global Financial Private Client LLC lifted its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the last quarter. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Robert W. Baird cut their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Truist Financial reduced their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Finally, Evercore ISI reduced their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Stock Down 0.1%

Shares of ISRG traded down $0.48 during trading hours on Friday, reaching $533.71. The company's stock had a trading volume of 2,014,026 shares, compared to its average volume of 1,675,502. The firm has a market cap of $191.29 billion, a price-to-earnings ratio of 78.26, a P/E/G ratio of 5.67 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The company has a 50 day moving average of $531.06 and a two-hundred day moving average of $536.83.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the company earned $1.50 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 215 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the transaction, the senior vice president now owns 1,768 shares in the company, valued at $970,738.08. This represents a 10.84% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.